Heated chemotherapy inside the bladder for bladder cancer that returned after BCG
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a treatment that puts heated chemotherapy directly into the bladder for people whose bladder cancer came back after BCG therapy. The goal is to control the cancer without needing to remove the bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high-grade bladder cancer that has not spread into the muscle layer (called non-muscle-invasive).
- You have had BCG therapy (a standard treatment for this cancer) and it did not work or you could not tolerate it.
- You cannot or choose not to have surgery to remove your bladder (radical cystectomy).
- You are generally well enough to care for yourself (score 0-2 on a standard activity scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called HIVEC (hyperthermic intravesical chemotherapy), which delivers heated chemotherapy directly into the bladder to help prevent bladder cancer from coming back. It may be an option for people with medium- or high-risk non-muscle-invasive bladder cancer who have not received this type of treatment before.
This trial compares two combinations of chemotherapy drugs given directly into the bladder to see which works better for patients whose bladder cancer has not responded to BCG therapy.
This trial tests a combination of chemotherapy placed directly into the bladder and an immunotherapy drug called pembrolizumab (given through a vein) for people with high-risk bladder cancer that has not completely responded to or has returned after BCG treatment.
This study tests a combination of two chemotherapy drugs, mitomycin-C and gemcitabine, given directly into the bladder for people with high-risk bladder cancer that hasn't been controlled with BCG therapy. It's an option for those who can't or don't want to have their bladder removed.
This study tests a more targeted way to treat low-grade bladder cancer using chemotherapy placed directly into the bladder. Before treatment, your cancer cells are grown in the lab to see which drug works best for you.
This trial studies adding “heat treatment” (hyperthermia) to standard bladder cancer care using radiation, sometimes with chemotherapy. It may help the radiation work better, but your eligibility depends on cancer stage, your general health, and certain heart and metal-safety issues.
Hear when a new Non Muscle Invasive Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.